CLOV vs IART · rev $1.37B vs rev $1.61B
Clover Health Investments Corp (CLOV) versus Integra LifeSciences Holdings (IART) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Integra LifeSciences Holdings (IART) is a medical devices company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported IART revenue for 2024-12-31 was $1.61B. Net income was -$6.9M. Revenue was up 4.5% from 2023-12-31 to 2024-12-31. IART currently screens at market cap $1.32B.
CLOV currently screens at market cap $1.55B. IART currently screens at market cap $1.32B.
Not investment advice. Open the CLOV and IART stock pages for the full models.
Not investment advice.